Showing results (1701-1710 of 1,770) with videos related to
Sort By:
Pageof 177
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutationsSharon J Sha, Zachary A Miller, Sang-Won Min, et al.Nature Microbiology|December 15, 2021
Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflowsKim A Lagerborg, Erica Normandin, Matthew R Bauer, et al.Journal of Global Oncology|September 23, 2018
Perspectives on Strengthening Cancer Research and Control in Latin America Through Partnerships and Diplomacy: Experience of the National Cancer Institute's Center for Global HealthSilvina Frech, Catherine A Muha, Lisa M Stevens, et al.Facial Plastic Surgery & Aesthetic Medicine|April 17, 2026
Features of Importance in the Nasal Exam in RhinoplastyElizabeth S Longino, Cherian K Kandathil, Jamil Ahmad, et al.Science (New York, N.Y.)|March 2, 2021
Targeting a neoantigen derived from a common TP53 mutationEmily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass, et al.Obesity Surgery|May 4, 2026
The Future of Obesity Care: Exploring Synergies Between Metabolic Bariatric Surgery, Interventional Endoscopy and PharmacotherapyWendy A Brown, Priya Sumithran, Michael Cowley, et al.Nature|March 28, 2024
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancersTushar D Nichakawade, Jiaxin Ge, Brian J Mog, et al.Cancers|May 28, 2022
Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer PatientsWhitney Espinel, Marjan Champine, Heather Hampel, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cellsJin Liu, Yuanxuan Xia, Brian J Mog, et al.Hepatology (Baltimore, Md.)|July 13, 2021
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE StudyMark S Sulkowski, Juhi S Moon, Kenneth E Sherman, et al.Pageof 177